Photodynamic therapy for malignant pleural mesothelioma: the future of treatment?

References

• Montanaro F, Rosato R, Gangemi M et al. Survival of pleural malignant mesothelioma in Italy: a population-based study. Int. J. Cancer124(1), 201–207 (2009).
   PubMed Web of Science ®Google Scholar
• Chapman A, Mulrennan S, Ladd B, Muers MF. Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax63(5), 435–439 (2008).
   Google Scholar
• Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol.21(14), 2636–2644 (2003).
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Wolf AS. Surgery for malignant pleural mesothelioma. Expert Rev. Respir. Med.4(3), 363–372 (2010).
   PubMedGoogle Scholar
• Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J. Thorac. Oncol.1(2), 175–176 (2006).
   PubMed Web of Science ®Google Scholar
• Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin. Thorac. Cardiovasc. Surg.21(2), 132–148 (2009).
   PubMedGoogle Scholar
• Flores RM. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin. Thorac. Cardiovasc. Surg.21(2), 149–153 (2009).
   PubMedGoogle Scholar
• Rice D. Surgery for malignant pleural mesothelioma. Ann. Diagn. Pathol.13(1), 65–72 (2009).
   Google Scholar
• Flores RM, Pass HI, Seshan VE et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J. Thorac. Cardiovasc. Surg.135(3), 620–626 (2008).
   PubMed Web of Science ®Google Scholar
• Baldini EH. Radiation therapy options for malignant pleural mesothelioma. Semin. Thorac. Cardiovasc. Surg.21(2), 159–163 (2009).
   Google Scholar
• Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn. Ther.7(2), 61–75 (2010).
   PubMed Web of Science ®Google Scholar
• Gorman A, Killoran J, O’Shea C, Kenna T, Gallagher WM, O’Shea DF. In vitro demonstration of the heavy-atom effect for photodynamic therapy. J. Am. Chem. Soc.126(34), 10619–10631 (2004).
   PubMed Web of Science ®Google Scholar
• Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol. Res.46(1–3), 216–226 (2010).
   PubMed Web of Science ®Google Scholar
• Korbelik M, Merchant S, Huang N. Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors. Photochem. Photobiol.85(6), 1418–1424 (2009).
   Google Scholar
• Park EK, Bae S-M, Kwak S-Y et al. Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model. Immunology124(4), 461–468 (2008).
   Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat. Rev. Cancer3(5), 380–387 (2003).
   PubMed Web of Science ®Google Scholar
• Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol.5(8), 497–508 (2004).
   PubMed Web of Science ®Google Scholar
• Bisland SK, Lilge L, Lin A, Rusnov R, Wilson BC. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem. Photobiol.80, 22–30 (2004).
   Google Scholar
• Wang H-W, Rickter E, Yuan M et al. Effect of photosensitizer dose on fluence rate responses to photodynamic therapy. Photochem. Photobiol.83(5), 1040–1048 (2007).
   Google Scholar
• Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med. Sci.24(2), 259–268 (2009).
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J. Natl Cancer Institute90(12), 889–905 (1998).
   PubMed Web of Science ®Google Scholar
• Friedberg JS, Mick R, Stevenson J et al. A Phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann. Thorac. Surg.75(3), 952–959 (2003).
   Google Scholar
• Temeck BK, Pass HI. Esophagopleural fistula: a complication of photodynamic therapy. South. Med. J.88(3), 271–274 (1995).
   PubMed Web of Science ®Google Scholar
• Friedberg JS. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma. Semin. Thorac. Cardiovasc. Surg.21(2), 177–187 (2009).
   Google Scholar
• Pass HI, DeLaney TF, Tochner Z et al. Intrapleural photodynamic therapy: results of a Phase I trial. Ann. Surg. Oncol.1(1), 28–37 (1994).
   Google Scholar
• Schouwink H, Rutgers ET, van der Sijp J et al. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results. Chest120(4), 1167–1174 (2001).
   PubMed Web of Science ®Google Scholar
• Moskal TL, Dougherty TJ, Urschel JD et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann. Thorac. Surg.66(4), 1128–1133 (1998).
   PubMed Web of Science ®Google Scholar
• Pass HI, Temeck BK, Kranda K et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann. Surg. Oncol.4(8), 628–633 (1997).
   PubMed Web of Science ®Google Scholar
• Friedberg JS, Mick R, Stevenson JP et al. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J. Clin. Oncol.22(11), 2192–2201 (2004).
   PubMed Web of Science ®Google Scholar
• Broomfield S, Currie A, van der Most RG et al. Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy. Cancer Res.65(17), 7580–7584 (2005).
   PubMed Web of Science ®Google Scholar
• Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer6(7), 535–545 (2006).
   PubMed Web of Science ®Google Scholar
• Gereke M, Jung S, Buer J, Bruder D. Alveolar type II epithelial cells present antigen to CD4+ T cells and induce Foxp3+ regulatory T cells. Am. J. Resp. Crit. Care Med.179(5), 344–355 (2009).
   PubMed Web of Science ®Google Scholar
• Bural GG, Torigian DA, Chen W, Houseni M, Basu S, Alavi A. Increased 18F-FDG uptake within the reticuloendothelial system in patients with active lung cancer on PET imaging may indicate activation of the systemic immune response. Hellenic J. Nucl. Med.13(1), 23–25 (2010).
   Google Scholar
• Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA303(11), 1070–1076 (2010).
   PubMed Web of Science ®Google Scholar
• Rusthoven KE, Pugh TJ. Stereotactic body radiation therapy for inoperable lung cancer. JAMA303(23), 2354–2355; author reply 2355 (2010).
   Google Scholar
• Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res.62(6), 1604–1608 (2002).
   PubMed Web of Science ®Google Scholar
• Preise D, Oren R, Glinert I et al. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol. Immunother.58(1), 71–84 (2009).
   PubMed Web of Science ®Google Scholar
• Kwitniewski M, Juzeniene A, Glosnicka R, Moan J. Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy? Photochem. Photobiol. Sci.7(9), 1011–1017 (2008).
   Google Scholar
• Bae S-M, Kim Y-W, Kwak S-Y et al. Photodynamic therapy-generated tumor cell lysates with CpG-oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells. Cancer Sci.98(5), 747–752 (2007).
   Google Scholar
• Korbelik M. Photodynamic therapy-generated cancer vaccines. Methods Mol. Biol.635, 147–153 (2010).
   Google Scholar
• Canti G, Calastretti A, Bevilacqua A, Reddi E, Palumbo G, Nicolin A. Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia. Neoplasma57(2), 184–188 (2010).
   PubMed Web of Science ®Google Scholar
• del Carmen MG, Rizvi I, Chang Y et al. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J. Natl Cancer Institute97(20), 1516–1524 (2005).
   PubMed Web of Science ®Google Scholar
• Hongrapipat J, Kopeckova P, Liu J, Prakongpan S, Kopecek J. Combination chemotherapy and photodynamic therapy with fab’ fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Mol. Pharm.5(5), 696–709 (2008).
   PubMed Web of Science ®Google Scholar
• Xie Q, Jia L, Liu YH, Wei CG. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo. World J. Gastroenterol.15(6), 737–741 (2009).
   Google Scholar
• Peng CL, Lai PS, Lin FH, Yueh-Hsiu Wu S, Shieh MJ. Dual chemotherapy and photodynamic therapy in an HT-29 human colon cancer xenograft model using SN-38-loaded chlorin-core star block copolymer micelles. Biomaterials30(21), 3614–3625 (2009).
   PubMed Web of Science ®Google Scholar
• Anand S, Honari G, Hasan T, Elson P, Maytin EV. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin. Cancer Res.15(10), 3333–3343 (2009).
   PubMed Web of Science ®Google Scholar
• Chio-Srichan S, Oudrhiri N, Bennaceur-Griscelli A, Turhan AG, Dumas P, Refregiers M. Toxicity and phototoxicity of hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate. J. Photochem. Photobiol. B Biol.99(2), 100–104 (2010).
   Google Scholar
• Bhuvaneswari R, Thong PSP, Gan YY, Soo KC, Olivo M. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy. J. Biomed. Optics15(1), 011114 (2010).
   Google Scholar
• Bhuvaneswari R, Gan YY, Soo KC, Olivo M. Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. Mol. Cancer8, 94 (2009).
   PubMedGoogle Scholar
• Bhuvaneswari R, Yuen GY, Chee SK, Olivo M. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins. Photochem. Photobiol. Sci.6(12), 1275–1283 (2007).
   Google Scholar
• Sharma P, Farrell T, Patterson MS et al.In vitro survival of nonsmall cell lung cancer cells following combined treatment with ionizing radiation and photofrin-mediated photodynamic therapy. Photochem. Photobiol.85(1), 99–106 (2009).
   Google Scholar
• Luksiene Z, Kalvelyte A, Supino R. On the combination of photodynamic therapy with ionizing radiation. J. Photochem. Photobiol. B Biol.52(1–3), 35–42 (1999).
   PubMed Web of Science ®Google Scholar
• Allman R, Cowburn P, Mason M. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. Br. J. Cancer83(5), 655–661 (2000).
   Google Scholar
• Madsen SJ, Sun CH, Tromberg BJ, Yeh AT, Sanchez R, Hirschberg H. Effects of combined photodynamic therapy and ionizing radiation on human glioma spheroids. Photochem. Photobiol.76(4), 411–416 (2002).
   Google Scholar
• Juzenas P, Chen W, Sun YP et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev.60(15), 1600–1614 (2008).
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol.6(4), 1159–1166 (2006).
   PubMed Web of Science ®Google Scholar
• Yanase S, Nomura J, Matsumura Y, Watanabe Y, Tagawa T. Synergistic increase in osteosarcoma cell sensitivity to photodynamic therapy with aminolevulinic acid hexyl ester in the presence of hyperthermia. Photomed. Laser Surg.27(5), 791–797 (2009).
   Google Scholar
• Labanauskiene J, Satkauskas S, Kirveliene V, Venslauskas M, Atkocius V, Didziapetriene J. Enhancement of photodynamic tumor therapy effectiveness by electroporation in vitro. Medicina (Kaunas, Lithuania)45(5), 372–377 (2009).
   Google Scholar
• Huygens A, Kamuhabwa AR, Van Laethem A et al. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation. Int. J. Oncol.26(6), 1691–1697 (2005).
   Google Scholar
• Madsen SJ, Mathews MS, Angell-Petersen E et al. Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids. J. Neurooncol.91(2), 141–149 (2009).
   PubMed Web of Science ®Google Scholar
• Schastak S, Yafai Y, Geyer W, Kostenich G, Orenstein A, Wiedemann P. Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation. Methods Find Exp. Clin. Pharmacol.30(1), 17–23 (2008).
   Google Scholar
• Ungun B, Prud’homme RK, Budijon SJ et al. Nanofabricated upconversion nanoparticles for photodynamic therapy. Opt. Express17(1), 80–86 (2009).
   PubMed Web of Science ®Google Scholar
• Chatterjee DK, Yong Z. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine3(1), 73–82 (2008).
   PubMed Web of Science ®Google Scholar
• Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol.26(11), 612–621 (2008).
   PubMed Web of Science ®Google Scholar
• Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug. Deliv. Rev.60(15), 1627–1637 (2008).
   PubMed Web of Science ®Google Scholar
• Liu F, Zhao B, Krug LM et al. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans. J. Thorac. Oncol.5(6), 879–884 (2010).
   PubMed Web of Science ®Google Scholar